Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:145435974" >
Associations Betwee...
-
Falhammar, HKarolinska Institutet
(författare)
Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population-Based Case-Control Study
- Artikel/kapitelEngelska2020
Förlag, utgivningsår, omfång ...
-
2020-04-14
-
The Endocrine Society,2020
Nummerbeteckningar
-
LIBRIS-ID:oai:prod.swepub.kib.ki.se:145435974
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:145435974URI
-
https://doi.org/10.1210/clinem/dgaa194DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
BackgroundCalcium channel blockers (CCBs), beta-receptor blockers (BBs), angiotensin-converting enzyme inhibitors (ACEIs), and angiotensin II receptor blockers (ARBs) have occasionally been reported to cause severe hyponatremia. The aim was to explore the association between CCBs, BBs, ACEIs, and ARBs and hospitalization due to hyponatremia.MethodsPatients hospitalized with a principal diagnosis of hyponatremia (n = 11 213) were compared with matched controls (n = 44 801). Linkage of national population-based registers was used to acquire data. Multivariable logistic regression adjusting for co-medications, diseases, previous hospitalizations, and socioeconomic factors was used to explore the association between hospitalization for severe hyponatremia and the use of different CCBs, BBs, ACEIs, and ARBs. Furthermore, newly initiated (≤90 days) and ongoing use were examined separately.ResultsAdjusted odds ratios (aORs) (95% confidence interval) for the investigated 4 drug classes ranged from 0.86 (0.81-0.92) for CCBs to 1.15 (1.07-1.23) for ARBs. For newly initiated drugs, aORs spanned from 1.64 (1.35-1.98) for CCBs to 2.24 (1.87-2.68) for ACEIs. In contrast, the corresponding associations for ongoing therapy were not elevated, ranging from 0.81 (0.75-0.86) for CCBs to 1.08 (1.00-1.16) for ARBs. In the CCBs subgroups, aOR for newly initiated vascular CCBs was 1.95 (1.62-2.34) whereas aOR for ongoing treatment was 0.82 (0.77-0.88).ConclusionsFor newly initiated CCBs, BBs, ACEIs, and ARBs, the risk of hospitalization due to hyponatremia was moderately elevated. In contrast, there was no evidence that ongoing treatment with investigated antihypertensive drugs increased the risk for hospitalization due to hyponatremia.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Skov, JKarolinska Institutet
(författare)
-
Calissendorff, JKarolinska Institutet
(författare)
-
Nathanson, DKarolinska Institutet
(författare)
-
Lindh, JDKarolinska Institutet
(författare)
-
Mannheimer, BKarolinska Institutet
(författare)
-
Karolinska Institutet
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:The Journal of clinical endocrinology and metabolism: The Endocrine Society105:101945-71970021-972X
Internetlänk
Hitta via bibliotek
Till lärosätets databas